Table 2.
Medications on admission and follow-up
| Drug | Admission (n; %) | Follow-up (n; %) |
|---|---|---|
| NSAIDs | ||
| Diclofenac | 13; 11.0 | 16; 13.6 |
| Ibuprofen | 16; 13.6 | 7; 5.9 |
| Paracetamol | 41; 34.8 | 41; 34.8 |
| Weak opioids | ||
| Codeine | 30; 25.4 | 31; 26.3 |
| Tramadol | 20; 16.9 | 24; 20.3 |
| Strong opioids | ||
| Buprenorphine | 1; 0.8 | 4; 3.4 |
| Fentanyl | 1; 0.8 | 4; 3.4 |
| Morphine | 3; 2.5 | 5; 4.2 |
| Oxycodone | 1; 0.8 | 4; 3.4 |
| Antidepressants | ||
| Amitriptyline | 11; 9.3 | 11; 9.3 |
| Duloxetine | 0 | 9; 7.6 |
| Anticonvulsants | ||
| Gabapentin | 6; 5.1 | 9; 7.6 |
| Pregabalin | 4; 3.4 | 32; 27.1 |
| Total prescriptions | 147; 125 | 197; 167 |
Notes: Medications are arranged by drug class. Percentage values are expressed for the total number of patients (n=118) in the final analysis. Because of frequent implementation of multimodal drug therapy, the number of prescriptions exceeds the total number of patients studied.
Abbreviation: NSAIDs, nonsteroidal anti-inflammatory drugs.